找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Cancer Chemotherapy: an Introduction; T. J. Priestman Book 1989Latest edition Springer-Verlag Berlin Heidelberg 1989 Drogen.antibiotics.br

[復(fù)制鏈接]
樓主: 瘦削
21#
發(fā)表于 2025-3-25 06:09:53 | 只看該作者
22#
發(fā)表于 2025-3-25 10:15:44 | 只看該作者
Resistance to Cytotoxic Drugs will reappear and the patient relapse despite continuing chemotherapy. This progression of disease during treatment indicates that the tumour has developed secondary resistance to the particular drugs being given. A change of agents at this time may well bring about a further remission.
23#
發(fā)表于 2025-3-25 12:13:14 | 只看該作者
24#
發(fā)表于 2025-3-25 16:02:09 | 只看該作者
25#
發(fā)表于 2025-3-25 21:03:53 | 只看該作者
26#
發(fā)表于 2025-3-26 02:55:55 | 只看該作者
27#
發(fā)表于 2025-3-26 05:45:54 | 只看該作者
Book 1989Latest editiong time, there have been numerous developments in cancer chemotherapy and in order to cover these the majority of the text has been completely revised and rewritten. In addition, two new chapters have been introduced, one on the safe handling of cytotoxic drugs and the other on biological response mo
28#
發(fā)表于 2025-3-26 10:26:11 | 只看該作者
29#
發(fā)表于 2025-3-26 15:17:11 | 只看該作者
Enkephalin and Endorphin Receptors,At least three agents with anti-oestrogenic properties have been used in cancer treatment: tamoxifen, clomiphene citrate and nafoxidene. It is tamoxifen, however, that has come to dominate this particular therapeutic area and the remainder of this discussion will be confined to this agent.
30#
發(fā)表于 2025-3-26 19:56:13 | 只看該作者
The Clinical Pharmacology of Endocrine DrugsAt least three agents with anti-oestrogenic properties have been used in cancer treatment: tamoxifen, clomiphene citrate and nafoxidene. It is tamoxifen, however, that has come to dominate this particular therapeutic area and the remainder of this discussion will be confined to this agent.
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-17 04:07
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
南昌县| 仙游县| 长乐市| 方城县| 同心县| 壤塘县| 荔浦县| 资阳市| 泽州县| 介休市| 炎陵县| 手机| 米脂县| 石泉县| 温州市| 仪陇县| 曲阳县| 申扎县| 伊宁县| 尚志市| 蕲春县| 祥云县| 手游| 沙坪坝区| 新乐市| 泗水县| 普格县| 类乌齐县| 林口县| 隆化县| 甘孜| 台东市| 泊头市| 和硕县| 任丘市| 墨竹工卡县| 永川市| 黎川县| 郓城县| 平和县| 浦城县|